Report Contents
Market Overview
The global catheter securement device market is entering a sustained expansion phase, with revenue projected to reach approximately USD 1,27 billion in 2026 and advance to about USD 1,94 billion by 2032, reflecting a compound annual growth rate of 7,30 percent over that period. This momentum builds on the current base as hospitals, ambulatory surgery centers, and home infusion providers prioritize complication reduction, line-stability, and infection control in vascular access management.
Growth is being driven by converging trends such as escalating chronic disease burdens, the shift toward outpatient and home-based care, and tightening standards for catheter-related bloodstream infection prevention. These forces are expanding the addressable scope of catheter securement solutions and reshaping competitive dynamics, placing strategic emphasis on scalable manufacturing, localization of product portfolios and regulatory strategies, and integration of advanced materials and digital monitoring technologies.
Within this context, the report serves as a critical strategic tool, delivering forward-looking analysis of capital allocation choices, partnership models, and technology bets that will determine market leadership. It equips investors, medtech manufacturers, and healthcare providers with actionable insights to anticipate disruptions, capture emerging opportunities, and navigate the industry’s structural transformation over the 2026–2032 horizon.
Market Growth Timeline (USD Billion)
Source: Secondary Information and ReportMines Research Team - 2026
Market Segmentation
The Catheter Securement Device Market analysis has been structured and segmented according to type, application, geographic region and key competitors to provide a comprehensive view of the industry landscape.
Key Product Application Covered
Key Product Types Covered
Key Companies Covered
By Type
The Global Catheter Securement Device Market is primarily segmented into several key types, each designed to address specific operational demands and performance criteria.
-
Peripheral Intravenous Catheter Securement Devices:
Peripheral intravenous catheter securement devices hold a significant portion of current procedural volumes because peripheral IV lines account for the majority of short-term vascular access in acute care and outpatient settings. These devices are widely adopted in emergency departments, surgical wards and infusion clinics to reduce line dislodgement, which can otherwise increase consumable usage and nursing time. As a result, they represent a stable and recurring revenue stream within the Global Catheter Securement Device Market.
Their competitive advantage lies in their ability to reduce accidental catheter removal and insertion-site complications by an estimated 30.00% to 50.00% compared with basic tape-based fixation. Many advanced peripheral IV securement platforms use integrated adhesive anchors and low-profile designs that improve patient mobility while maintaining high pull-out resistance. This performance advantage translates into lower reinsertion costs and fewer therapy disruptions for high-throughput infusion services.
Growing volumes of outpatient chemotherapy, biologic infusions and home-based IV therapy are the primary catalysts driving demand for peripheral IV securement solutions. Health systems are under cost-containment pressure to cut avoidable complications, which is pushing procurement teams toward standardized, evidence-based securement products. In parallel, training initiatives focused on vascular access safety are encouraging hospitals to upgrade from legacy tape methods to dedicated peripheral intravenous catheter securement devices.
-
Central Venous Catheter Securement Devices:
Central venous catheter securement devices occupy a critical position in the market because central lines are used in high-acuity settings such as intensive care units, oncology centers and major operating rooms. The financial and clinical impact of central line dislodgement or bloodstream infection is substantially higher than for peripheral access, which elevates the strategic importance of securement in this segment. Consequently, central venous catheter securement devices command premium pricing and contribute disproportionately to value within the overall catheter securement device market.
Their competitive advantage is built on specialized designs that integrate stabilization, site visibility and moisture management to reduce central line–associated complications. Many systems demonstrate reductions in catheter migration and dressing disruption of more than 40.00% compared with generic adhesive approaches, directly lowering the risk of central line–associated bloodstream infections. This level of performance makes them preferred options in institutions that track infection rates and device-related events as key quality indicators.
Stricter infection-prevention protocols, accreditation standards and reimbursement penalties for avoidable central line infections are the principal catalysts boosting adoption of central venous catheter securement technologies. Hospitals increasingly incorporate these devices into standardized central line insertion and maintenance bundles to comply with regulatory expectations. As critical care capacity expands in emerging markets, demand for robust central venous catheter securement solutions is expected to grow in tandem with intensive care procedure volumes.
-
Arterial Catheter Securement Devices:
Arterial catheter securement devices serve a specialized but vital segment focused on hemodynamic monitoring and frequent arterial blood sampling in surgical and critical care environments. While the installed base of arterial lines is smaller than that of peripheral IVs, the clinical risk associated with dislodgement or bleeding is substantially higher, which elevates the strategic importance of securement in this category. As a result, these devices maintain a solid niche position within the broader market, particularly in tertiary hospitals and cardiac centers.
Their competitive advantage stems from designs that combine high tensile strength and kink resistance with secure yet comfortable skin adhesion. Many arterial line securement systems provide pull-out resistance improvements of 25.00% to 40.00% over conventional taping, which stabilizes the catheter during patient movement and repositioning. This stability enables more reliable continuous blood pressure monitoring and reduces the need for re-cannulation, which is especially valuable in operating rooms and intensive care units with high workflow intensity.
Growth in complex cardiovascular procedures, including transcatheter interventions and advanced cardiac surgeries, is a central catalyst for this type. As more health systems equip operating theaters and ICUs with invasive monitoring capabilities, demand rises for arterial catheter securement devices that comply with safety protocols and maintain line integrity during extended procedures. Additionally, initiatives to minimize blood loss and needlestick exposure reinforce the adoption of dedicated arterial securement solutions over improvised fixation methods.
-
Urinary Catheter Securement Devices:
Urinary catheter securement devices represent one of the largest and most visible segments because indwelling Foley catheters are widely used across general wards, long-term care facilities and post-surgical units. Uncontrolled movement of urinary catheters can cause urethral trauma, discomfort and catheter-associated urinary tract infections, which makes securement a high-impact intervention for patient safety programs. Their broad clinical footprint gives urinary catheter securement products a strong installed base and steady replacement-driven demand.
The competitive advantage of these devices lies in their ability to reduce traction on the catheter and maintain stable positioning on the thigh or abdomen. Compared with improvised tape-based methods, dedicated urinary catheter holders can cut unintentional catheter tugging and partial dislodgement events by an estimated 35.00% to 60.00%. This improved stability reduces the likelihood of micro-movements at the urethral meatus, which are associated with irritation, pain and increased infection risk.
The main growth catalyst for urinary catheter securement devices is the global focus on reducing catheter-associated urinary tract infections as a reportable quality metric. Hospitals and nursing homes are increasingly implementing standardized catheter care bundles that include mandatory securement solutions. Rising elderly populations and higher rates of chronic conditions such as neurogenic bladder and post-stroke urinary retention further expand the utilization base for urinary catheter securement devices worldwide.
-
Epidural Catheter Securement Devices:
Epidural catheter securement devices address a more specialized but clinically sensitive area within anesthesiology and pain management. Epidural catheters are used for obstetric analgesia, post-operative pain control and chronic pain therapies, where unplanned migration can compromise analgesic distribution or cause treatment failure. Because of these high stakes, securement in this segment is viewed as a critical safety and efficacy factor rather than a minor procedural accessory.
Their competitive advantage is linked to designs that contour to the back and maintain position despite patient movement, perspiration and extended wear times. Compared with basic dressings, dedicated epidural securement systems can decrease catheter migration and unintended removal by an estimated 30.00% to 50.00%, helping maintain consistent analgesic delivery. Some platforms incorporate transparent windows that allow clinicians to inspect the insertion site without disrupting the securement, further improving safety and workflow efficiency.
Growth in regional anesthesia techniques and enhanced recovery after surgery protocols is a primary driver for epidural catheter securement products. As more surgical procedures shift to multimodal pain management strategies that rely on neuraxial blocks, demand increases for reliable securement that supports prolonged epidural use. Additionally, anesthesia departments are standardizing equipment choices to reduce variability and complications, which favors dedicated epidural catheter securement devices over improvised or generic options.
-
Peripherally Inserted Central Catheter (PICC) Securement Devices:
PICC securement devices occupy a strategically important position in the market because PICC lines bridge the gap between central venous access and longer-term outpatient therapy. They are heavily used in oncology, infectious disease management and home infusion, where catheter failure can disrupt multi-week treatment plans. As a result, PICC securement solutions are considered high-value components of vascular access programs and contribute substantially to premium revenue within the catheter securement device market.
These devices distinguish themselves by providing high stabilization performance without relying solely on sutures, thereby reducing needlestick risk and skin trauma. Many advanced PICC securement technologies show reductions in catheter dislodgement and unplanned replacement by 45.00% or more compared with sutures or basic tape dressings. Some systems use subcutaneous anchors or engineered adhesive platforms that can maintain securement for several weeks, aligning with typical PICC dwell times and improving treatment continuity.
Increased reliance on outpatient and home-based infusion therapy is the major growth catalyst for PICC securement devices. Payers and providers are shifting complex therapies away from inpatient settings to reduce costs, which amplifies the need for reliable, low-maintenance catheter stabilization in non-hospital environments. Policies that encourage sutureless securement to enhance needlestick safety also support adoption of dedicated PICC securement technologies across both developed and emerging healthcare markets.
-
Nasogastric and Enteral Tube Securement Devices:
Nasogastric and enteral tube securement devices serve a critical role in nutrition support, medication administration and gastric decompression for patients unable to swallow safely. These devices are widely used in intensive care, neonatology, oncology and long-term care settings, making them an important contributor to procedural volumes within the Global Catheter Securement Device Market. Because accidental tube removal can interrupt feeding and increase aspiration risk, securement is a frontline patient-safety issue.
Their competitive advantage stems from tailored designs that conform to facial contours and minimize pressure on the nares while resisting pull-out forces from coughing, agitation or routine handling. Compared with standard tape methods, dedicated nasogastric and enteral tube securement devices can reduce tube dislodgement rates by an estimated 30.00% to 55.00%. This improvement helps avoid repeated radiographic confirmation, reduces sedation use in agitated patients and limits delays in achieving nutritional targets.
Rising emphasis on early enteral nutrition in critical care and oncology is the key catalyst accelerating adoption of these securement products. Guidelines that prioritize enteral feeding over parenteral nutrition drive more frequent placement of nasogastric and feeding tubes, which amplifies the impact of securement failures. Additionally, the growth of pediatric and neonatal intensive care units increases demand for specialized, skin-friendly securement solutions designed for smaller, more fragile patients.
-
Securement Dressings and Adhesive Anchoring Devices:
Securement dressings and adhesive anchoring devices form a broad, cross-cutting category that supports multiple catheter types, including peripheral IVs, central lines and arterial catheters. These products often function as the default stabilization method in many hospitals due to their versatility, relatively low unit cost and compatibility with existing insertion protocols. Their wide applicability gives this segment a substantial share of the total catheter securement device market across both high- and middle-income countries.
The primary competitive advantage of securement dressings and adhesive anchors lies in their combination of transparent films, absorbent pads and engineered adhesives that maintain line stability while allowing site visualization. Many advanced dressings demonstrate wear times of up to 7.00 days and can reduce dressing-related disruptions and minor dislodgement events by roughly 20.00% to 40.00% compared with generic film or gauze solutions. Some platforms incorporate integrated stabilization strips or border designs that distribute mechanical stress, enhancing overall catheter security without additional hardware.
The strongest growth catalyst for this segment is the standardization of vascular access care bundles that specify particular dressing change intervals and securement practices. As hospitals adopt evidence-based protocols and seek to reduce product variation across departments, they increasingly contract for integrated dressing and anchoring systems from a limited number of vendors. Furthermore, migration toward single-use, pre-packaged insertion kits that include dedicated securement dressings is reinforcing consistent utilization and expanding global demand.
Market By Region
The global Catheter Securement Device market demonstrates distinct regional dynamics, with performance and growth potential varying significantly across the world's major economic zones.
The analysis will cover the following key regions: North America, Europe, Asia-Pacific, Japan, Korea, China, USA.
-
North America:
North America represents a strategically critical hub for the catheter securement device market, driven by high procedure volumes in interventional cardiology, oncology and critical care. The United States and Canada act as the primary engines of demand due to advanced hospital networks, widespread adoption of central venous catheters and strong infection-control protocols. The region accounts for a significant portion of the global market, providing a mature, stable revenue base that anchors global sales and shapes product standards.
Untapped potential lies in community hospitals, long-term care facilities and home infusion therapy, where securement practices remain inconsistent. Rural healthcare providers often face constraints in staff training and budget, which limits uptake of premium engineered stabilization devices. Addressing these gaps through value-based pricing models, nurse education programs and bundled offerings with vascular access devices can unlock incremental growth, while regulatory scrutiny on catheter-related bloodstream infections continues to favor high-performance securement solutions.
-
Europe:
Europe holds strategic importance as a diversified and highly regulated market for catheter securement devices, with strong emphasis on patient safety and standardized vascular access protocols. Germany, the United Kingdom, France and the Nordic countries function as leading markets, supported by universal healthcare systems and high penetration of peripheral and central line procedures. The region contributes a substantial share of global revenues and is characterized by steady, policy-driven growth rather than rapid volume expansion.
Significant opportunity exists in Southern and Eastern European countries, where adoption of advanced securement devices trails Western Europe. Budget constraints and legacy use of adhesive tapes or sutures remain barriers to conversion. Vendors that provide health economic evidence demonstrating reduced catheter dislodgement, fewer dressing changes and lower infection rates can improve procurement decisions. Collaborative training with vascular access teams and integration into hospital infection-prevention programs will be critical to unlocking this latent demand and harmonizing standards across the continent.
-
Asia-Pacific:
The broader Asia-Pacific region, excluding Japan, Korea and China as separately analyzed markets, is emerging as a high-growth frontier for catheter securement devices. Economies such as India, Australia, Southeast Asian nations and New Zealand are increasing investments in acute care infrastructure, oncology centers and dialysis facilities. Although the region currently represents a smaller share of global revenues compared with North America and Europe, its contribution to incremental global growth is expanding rapidly as procedure volumes accelerate.
Untapped potential is particularly notable in populous countries like India, Indonesia and the Philippines, where large public hospital systems still rely heavily on low-cost adhesive methods. Challenges include price sensitivity, uneven reimbursement frameworks and limited awareness of the long-term cost savings associated with engineered securement. Companies that tailor product portfolios to tiered hospital segments and offer training for vascular access nurses can gain early-mover advantage, especially in rural tertiary-care hospitals and expanding private hospital chains.
-
Japan:
Japan occupies a strategically important niche in the catheter securement device market due to its aging population, high prevalence of chronic diseases and sophisticated hospital infrastructure. The country serves as a regional benchmark for clinical quality, with strong adherence to vascular access guidelines in large university hospitals and cancer centers. Japan accounts for a meaningful but moderate share of global market size, contributing stable, technology-driven demand rather than very high-volume expansion.
Growth opportunities lie in standardizing securement practices across smaller regional hospitals and long-term care facilities, where traditional dressing methods may still be common. Regulatory and reimbursement environments favor products that demonstrate clear clinical and economic benefits, such as reduced catheter migration and fewer line replacements. Manufacturers that localize product design for Japanese workflow preferences and partner with professional nursing societies on education can deepen market penetration and reinforce recurring revenue streams in this relatively mature yet under-optimized market.
-
Korea:
Korea represents a dynamic, technology-forward market for catheter securement devices, underpinned by advanced tertiary hospitals and strong digital health capabilities. Large university medical centers in Seoul and other major cities drive adoption, particularly in intensive care, interventional radiology and oncology infusion services. While Korea contributes a smaller portion of global revenues compared with the United States or major European countries, its growth rate is notable and aligned with the global compound annual growth trend of approximately 7.30 percent.
Untapped potential exists in mid-sized regional hospitals and ambulatory surgery centers, where cost pressures can limit upgrades from basic tape-based securement. Regulatory expectations around infection control are tightening, creating a favorable environment for evidence-backed securement solutions. Suppliers that provide integrated catheter securement kits, localized clinical data and training for vascular access teams can accelerate conversion. Expanding into home-based therapies such as peritoneal dialysis and home infusion also offers incremental demand for user-friendly securement devices.
-
China:
China has become one of the most strategically significant growth engines in the global catheter securement device market, driven by rapid hospital expansion, rising surgical volumes and intensifying focus on healthcare quality. Major urban centers such as Beijing, Shanghai and Guangzhou dominate early adoption, supported by large tertiary hospitals and oncology institutes. China's share of the global market is increasing steadily, contributing a disproportionate portion of incremental volume growth as the overall market is projected to expand from about 1.18 Billion in 2,025 to 1.94 Billion by 2,032.
Despite strong urban demand, substantial untapped potential remains in county-level hospitals and rural medical institutions, where budgets and training for advanced securement devices lag behind metropolitan peers. Domestic manufacturers compete aggressively on price, while international brands differentiate through infection-prevention performance and quality assurance. Strategies that combine tiered product lines, localized manufacturing and education on catheter-related complication reduction can capture this latent demand and align with government initiatives to upgrade care standards nationwide.
-
USA:
The USA is the single most influential national market for catheter securement devices, setting clinical practice benchmarks and driving product innovation. High utilization of central venous catheters, peripherally inserted central catheters and arterial lines across intensive care units, oncology centers and interventional suites supports substantial recurring demand. The USA accounts for a large share of global revenues and serves as the primary anchor of the North American contribution to a global market expected to grow from 1.18 Billion in 2,025 to 1.27 Billion in 2,026 and further to 1.94 Billion by 2,032.
Although penetration of engineered securement devices is already high in major health systems, opportunities persist in standardizing protocols across smaller community hospitals, outpatient infusion centers and home health agencies. Reimbursement pressures and value-based care models favor products that document reduced complications, shorter hospital stays and lower total cost of care. Suppliers that integrate securement devices into comprehensive vascular access bundles, supported by real-world data and clinician training, can deepen account share and sustain growth in this otherwise mature, highly competitive environment.
Market By Company
The Catheter Securement Device market is characterized by intense competition, with a mix of established leaders and innovative challengers driving technological and strategic evolution.
-
3M Company:
3M Company occupies a central position in the catheter securement device market due to its broad advanced adhesive portfolio, infection-prevention technologies, and long-standing relationships with acute care hospitals and ambulatory surgery centers. The company leverages its expertise in medical tapes, transparent dressings, and skin-friendly adhesives to deliver securement solutions that reduce catheter dislodgement and catheter-related bloodstream infection risk, which makes it a preferred vendor in many integrated delivery networks.
In 2025, 3M’s catheter securement device business is estimated to generate revenue of USD 0.24 Billion, representing a market share of approximately 20.50%. These figures indicate that 3M is one of the largest players in this segment, benefiting from economies of scale, strong distribution networks, and high brand trust among clinicians. Its sizable share underscores its ability to influence pricing structures, product standards, and clinical protocol adoption across key regions.
3M’s strategic advantage lies in its cross-segment innovation engine and its ability to integrate catheter securement devices with broader infection control bundles, such as antimicrobial dressings and barrier films. The company differentiates itself through evidence-backed performance, consistent product quality, and robust health economics data that demonstrate reduced catheter complications and lower total cost of care. Compared with smaller competitors, 3M can rapidly scale new product introductions globally and support hospitals with education, clinical training, and outcome-focused contracting models.
-
Becton, Dickinson and Company:
Becton, Dickinson and Company (BD) plays a pivotal role in the catheter securement device market because it is a leading manufacturer of vascular access catheters, infusion therapy systems, and related disposables. By combining catheter hardware with integrated securement solutions, BD offers clinicians a unified platform that simplifies procurement and standardizes insertion and maintenance protocols across wards and outpatient infusion centers.
For 2025, BD’s catheter securement device revenue is estimated at USD 0.19 Billion, corresponding to a market share of about 16.30%. This performance confirms BD as a top-tier competitor with significant leverage in negotiations with group purchasing organizations and large hospital chains. Its integrated vascular access portfolio helps capture a significant portion of new catheter placements, reinforcing its competitive moat against specialized but narrower rivals.
BD’s core capabilities include deep clinical insight into infusion therapy workflows, comprehensive product lines that span from peripheral IV catheters to central venous catheters, and strong competencies in safety-engineered devices. The company differentiates itself by promoting complete vascular access management solutions, where securement devices are bundled with needleless connectors, antimicrobial caps, and closed drug delivery systems. This systems-based approach enables BD to lock in customers through long-term contracts, outcome guarantees, and compatibility advantages that smaller securement-only players cannot easily match.
-
C. R. Bard:
C. R. Bard, now operating within a larger diversified medical device group, has a long-standing heritage in vascular access, urology, and oncology-related catheterization products. Within the catheter securement device market, Bard is particularly relevant for central line and peripherally inserted central catheter (PICC) securement solutions deployed in oncology centers, intensive care units, and home infusion programs.
In 2025, Bard’s catheter securement device business is estimated to generate revenue of USD 0.14 Billion, translating into a market share of around 12.10%. These numbers position Bard as a strong, upper-tier competitor with pronounced strength in high-acuity and long-dwell catheter segments. The concentration of its portfolio in clinically complex use cases allows Bard to command premium pricing, albeit with a narrower volume base than broader portfolio players.
Bard’s competitive differentiation stems from its specialized focus on securement for high-risk catheters, integrating features such as sutureless fixation, antimicrobial materials, and engineered platforms that minimize insertion-site trauma. The company leverages its clinical evidence in oncology and critical care to promote protocols where securement devices are standard-of-care alongside central line kits. Compared with generalist suppliers, Bard’s depth in specific therapeutic areas enables it to develop highly tailored devices and collaborate closely with key opinion leaders on guidelines and quality improvement initiatives.
-
B. Braun Melsungen AG:
B. Braun Melsungen AG is a major European-based provider of infusion therapy, anesthesia, and intensive care products, and it extends this footprint into the catheter securement device market. The company is particularly visible in European hospitals and emerging markets where its IV therapy systems, infusion pumps, and disposables are widely adopted, creating natural pull-through demand for compatible securement solutions.
For 2025, B. Braun’s catheter securement revenue is projected at USD 0.09 Billion, corresponding to a market share of approximately 7.60%. This mid-to-upper tier positioning reflects its strong regional dominance in Europe and growing penetration in Latin America and Asia-Pacific, although it faces more intense competition in North America. Its share indicates a robust, yet still expandable, presence that can benefit from cross-selling into its existing infusion therapy installed base.
B. Braun’s strategic advantage lies in its integrated IV therapy ecosystems and its focus on patient safety and standardized care pathways. The company can embed catheter securement devices into procedural kits and care bundles, making it easier for hospital purchasing departments to adopt a single supplier strategy. Compared with some U.S.-centric rivals, B. Braun brings strong regulatory and logistical expertise in European and Middle Eastern markets, enabling more agile market entry and tenders in those regions.
-
Smiths Medical:
Smiths Medical, now part of a larger healthcare platform, has a well-established presence in critical care, anesthesia, and vascular access products. In the catheter securement device market, the company is recognized for securement solutions that integrate with its arterial lines, central venous catheters, and pressure monitoring systems commonly used in operating rooms and intensive care units.
In 2025, Smiths Medical’s catheter securement revenue is estimated at USD 0.07 Billion, equating to a market share of about 5.90%. This share reflects a solid, yet not dominant, position where the company leverages synergies with its broader critical care portfolio rather than competing purely on securement volume. Its presence is particularly notable in institutions that standardize on Smiths’ monitoring and infusion platforms.
Smiths Medical differentiates itself through engineering-driven designs that enhance line stability in high-motion environments, such as pediatric units and transport settings. The company’s core capabilities include ergonomic device design, human-factor engineering, and integration with hemodynamic monitoring systems. By packaging securement devices alongside arterial and central line kits, Smiths delivers workflow efficiencies that appeal to anesthesiologists and intensivists who prioritize quick, secure line fixation during complex procedures.
-
ConvaTec Group PLC:
ConvaTec Group PLC brings its expertise in advanced wound care, ostomy care, and continence care to the catheter securement device market, particularly through skin-friendly adhesives and dressings. Its solutions are often selected in patients with fragile skin, such as the elderly or those with chronic comorbidities, where standard adhesives can cause medical adhesive–related skin injury.
For 2025, ConvaTec’s catheter securement revenue is projected at USD 0.06 Billion, which represents a market share of around 5.10%. This moderate share signals a focused but growing franchise that leverages cross-selling opportunities in wound and ostomy care. As healthcare providers increasingly prioritize skin integrity and patient comfort, ConvaTec is well positioned to expand its presence in both acute and home care settings.
The company’s strategic advantage is rooted in its advanced hydrocolloid and silicone adhesive technologies, which offer atraumatic removal and sustained adhesion in moist or mobile anatomical sites. Compared with more hardware-centric competitors, ConvaTec emphasizes dermatologic compatibility and long-wear performance. This positioning resonates with wound care nurses and home health providers who manage patients with long-term catheterization needs and who seek to reduce skin breakdown and reapplication frequency.
-
Medtronic plc:
Medtronic plc, as one of the world’s largest medical technology companies, participates in the catheter securement device market primarily through securement solutions integrated with cardiac, neurovascular, and interventional radiology catheters. Its relevance is strongest in advanced procedural environments, including catheterization laboratories, electrophysiology suites, and hybrid operating rooms where complex device leads and sheaths require stable fixation.
In 2025, Medtronic’s catheter securement-related revenue is estimated at USD 0.08 Billion, corresponding to a market share of approximately 6.80%. While this share is smaller than its dominance in many implantable device categories, it still reflects substantial scale given the specialized nature of its securement applications. Medtronic’s participation in this segment underscores the importance of securement in ensuring procedural success and long-term device performance.
Medtronic’s core strengths are its deep clinical ties in cardiology and neurology and its robust R&D capabilities for procedure-specific fixation solutions. The company differentiates itself by designing securement devices that complement proprietary catheters and leads, thus improving overall system reliability. This strategy allows Medtronic to lock in customers to complete procedural suites, while competitors without integrated securement offerings must rely more heavily on stand-alone product sales.
-
Mölnlycke Health Care:
Mölnlycke Health Care is a prominent provider of advanced wound care and surgical solutions, and it has leveraged this expertise to build a strong presence in catheter securement devices, especially transparent dressings and fixation products for IV and central lines. Its products are widely used in European hospitals and increasingly adopted in North America for infection prevention and securement of peripheral catheters.
For 2025, Mölnlycke’s catheter securement revenue is projected at USD 0.05 Billion, giving it a market share of about 4.20%. This share highlights a meaningful but still expandable position, driven largely by the success of its advanced dressings in preventing site contamination and improving visibility of insertion sites. The company’s strong brand in wound management supports premium pricing and facilitates formulary inclusion.
Mölnlycke’s competitive advantage lies in its evidence-based wound care technologies, user-friendly dressing designs, and strong partnerships with infection-control teams. The company emphasizes transparent dressings that combine securement with moisture management and bacterial barrier properties, helping clinicians meet stringent hospital-acquired infection reduction targets. Compared with hardware-focused competitors, Mölnlycke focuses on dressing optimization, patient comfort, and simplified application, which resonates with busy nursing staff.
-
Cardinal Health:
Cardinal Health is a major distributor and manufacturer of medical supplies, and it plays an important role in the catheter securement device market through private-label securement dressings, stabilization devices, and procedural kits. Its extensive distribution network to hospitals, ambulatory surgery centers, and physician offices allows it to place securement products alongside a wide range of clinical consumables.
In 2025, Cardinal Health’s catheter securement device revenue is estimated at USD 0.07 Billion, corresponding to a market share of roughly 6.10%. This share demonstrates the power of its logistics capabilities and contracting strength with large health systems, even though its product portfolio may be less differentiated technologically than some specialized competitors. Cardinal’s presence ensures that cost-sensitive providers have access to reliable, standardized securement options.
Cardinal Health’s strategic advantages include its large-scale distribution infrastructure, strong relationships with group purchasing organizations, and ability to bundle catheter securement devices within procedure packs and custom kits. The company competes effectively on price, supply reliability, and inventory management solutions. Compared with innovation-focused rivals, Cardinal emphasizes value, consistency, and ease of procurement, making it an attractive partner for health systems looking to streamline suppliers and reduce total supply chain costs.
-
Teleflex Incorporated:
Teleflex Incorporated is a significant innovator in vascular access and airway management, and it translates this innovation into the catheter securement device market through sutureless securement systems and dedicated stabilization devices for central and arterial lines. Its products are widely used in critical care and operating room settings where rapid application and strong securement are essential.
For 2025, Teleflex’s catheter securement revenue is projected at USD 0.06 Billion, equating to a market share of about 5.20%. This market position highlights Teleflex as a notable competitor with particular strength in high-acuity use cases. Its securement systems often become part of standard kits used for central line placement, enabling recurring sales tied to procedural volume.
Teleflex’s core capabilities involve engineering ergonomic, sutureless securement solutions that reduce needlestick risk and procedural time. The company differentiates itself through devices that are easy to apply, minimize skin trauma, and maintain catheter stability even in restless or mobile patients. Compared with dressing-focused competitors, Teleflex emphasizes mechanical stabilization and suture replacement, which aligns with hospital initiatives to reduce sharps injuries and streamline central line insertion workflows.
-
TIDI Products LLC:
TIDI Products LLC is a specialized manufacturer of single-use medical products focused on infection prevention and patient safety. In the catheter securement device market, TIDI participates through securement devices and dressings that are often included in sterile barriers, drapes, and procedure kits used in outpatient clinics, emergency departments, and minor procedure rooms.
In 2025, TIDI’s catheter securement revenue is estimated at USD 0.03 Billion, representing a market share of approximately 2.80%. This share reflects a niche but strategically important role, particularly in settings where disposable barriers and procedure packs are standard practice. TIDI’s ability to provide cost-effective, ready-to-use kits enables it to capture business from facilities seeking simplified infection control protocols.
TIDI’s competitive strengths include flexible manufacturing for custom kits, responsiveness to clinical feedback, and a focus on practical infection-prevention solutions. The company differentiates itself by integrating catheter securement devices into broader sterile field products, reducing the need for separate sourcing. Compared with larger multinational competitors, TIDI competes through customization, speed to market, and strong relationships with outpatient and office-based providers.
-
Marpac Inc.:
Marpac Inc. is a smaller, specialized player known for patient comfort and securement accessories, particularly within respiratory care and neonatal intensive care. In the catheter securement device market, Marpac focuses on soft, adjustable securement solutions designed to minimize skin irritation and pressure points, which makes them suitable for pediatrics, neonates, and long-term care patients.
For 2025, Marpac’s catheter securement revenue is projected at USD 0.02 Billion, corresponding to a market share of about 1.70%. This modest share indicates a targeted, niche strategy rather than broad market coverage. Nevertheless, Marpac’s products often occupy critical roles in specialized units where standard securement devices may not be clinically appropriate.
Marpac’s strategic advantage is its focus on comfort-driven design and patient-centric materials, including soft textiles and gentle fasteners. The company differentiates itself by addressing use cases that major players sometimes under-serve, such as securing catheters in very small or highly sensitive patients. This specialization allows Marpac to build loyalty among clinicians in neonatal and pediatric intensive care, even without the scale of larger competitors.
-
Halyard Health:
Halyard Health, now aligned with a broader medtech platform, has strong roots in infection prevention, surgical drapes, and barrier products. Within the catheter securement device market, Halyard leverages these strengths to offer securement solutions and dressings that integrate seamlessly into procedural draping and sterile field setups for surgery and interventional radiology.
In 2025, Halyard’s catheter securement device revenue is estimated at USD 0.03 Billion, equating to a market share of roughly 2.90%. This positioning reflects a focused role where securement devices complement a broader infection-prevention portfolio. Its products often enter hospitals through contracts that cover drapes, gowns, and sterilization wraps, then expand to include securement devices as part of standardized kits.
Halyard’s competitive differentiation stems from its expertise in barrier protection, strong brand recognition in operating rooms, and ability to bundle securement products with high-volume surgical consumables. Compared with pure-play securement device manufacturers, Halyard can use its established footprint in perioperative environments to drive adoption, particularly in facilities seeking single-source suppliers for infection-prevention categories.
-
Centurion Medical Products:
Centurion Medical Products is recognized for its procedural kits, vascular access products, and infection-prevention solutions, which naturally extend into the catheter securement device market. The company frequently packages securement devices within comprehensive kits for central line insertion, urinary catheterization, and arterial line placement, making securement a standard component of its turnkey procedural offerings.
For 2025, Centurion’s catheter securement revenue is projected at USD 0.02 Billion, representing a market share of approximately 1.90%. This share points to a focused yet strategically important role in procedure-based environments, particularly in North American hospitals that rely on ready-to-use kits to streamline workflows and support infection-control protocols.
Centurion’s strategic advantage lies in its capability to customize kits to hospital-specific protocols, ensuring that the chosen catheter securement device is consistently available at the point of care. The company differentiates itself by tailoring solutions for vascular access teams, emergency departments, and interventional radiology suites, aligning its offerings with hospital quality metrics such as reduced catheter-related infections and fewer line dislodgements. This integration-centric approach helps Centurion compete effectively despite its smaller overall scale.
-
Vygon SA:
Vygon SA is a France-based medical device company with a strong focus on vascular access, neonatology, and critical care. In the catheter securement device market, Vygon provides securement solutions that complement its lines of peripheral and central venous catheters, particularly in neonatal and pediatric care across Europe, the Middle East, and Latin America.
In 2025, Vygon’s catheter securement revenue is estimated at USD 0.02 Billion, giving it a market share of about 1.80%. This share illustrates a targeted presence tied closely to its vascular access portfolio and strong regional focus. While its global scale is smaller than that of multinational giants, Vygon holds influential positions in specialized pediatric and neonatal centers.
Vygon’s competitive strengths include deep expertise in small-caliber catheters, patient-size-specific devices, and clinician education for delicate patient populations. The company differentiates itself with securement solutions adapted to low-weight and preterm infants, where standard devices may be too large or aggressive for fragile skin. This specialized positioning allows Vygon to build high loyalty among neonatologists and pediatric intensivists and supports its broader strategy of being a reference supplier in neonatal and pediatric intensive care units.
Key Companies Covered
3M Company
Becton, Dickinson and Company
C. R. Bard
B. Braun Melsungen AG
Smiths Medical
ConvaTec Group PLC
Medtronic plc
Mölnlycke Health Care
Cardinal Health
Teleflex Incorporated
TIDI Products LLC
Marpac Inc.
Halyard Health
Centurion Medical Products
Vygon SA
Market By Application
The Global Catheter Securement Device Market is segmented by several key applications, each delivering distinct operational outcomes for specific industries.
-
Hospitals:
Hospitals represent the largest and most established application segment, with catheter securement devices deployed across intensive care units, medical–surgical wards, oncology units and perioperative departments. The core business objective in this setting is to reduce device-related complications, such as dislodgement and infection, which directly impact length of stay, readmission rates and procedure throughput. A significant portion of hospital-based vascular access procedures now rely on dedicated securement solutions rather than improvised taping, underscoring their central role in modern acute-care workflows.
Adoption is justified by measurable operational gains, including reductions in unplanned catheter replacement and line-associated adverse events. Many hospitals report decreases in catheter dislodgement of 30.00% to 50.00% after standardizing securement technology, which translates into fewer procedure interruptions and lower use of consumables and staff time. This performance improvement supports faster turnover of beds and procedure rooms, effectively improving throughput without additional capital investment.
The primary growth catalyst in hospitals is the combination of regulatory pressure and value-based reimbursement models that penalize preventable complications. Quality programs that track central line–associated bloodstream infections and catheter-associated urinary tract infections are pushing hospital administrators to mandate advanced securement as part of standardized care bundles. At the same time, rising patient acuity and growing surgical case volumes increase the number of catheters placed per admission, further expanding demand for reliable securement solutions in the hospital environment.
-
Ambulatory Surgical Centers:
Ambulatory surgical centers use catheter securement devices to support short-stay procedures that require reliable vascular access, regional anesthesia or urinary drainage during and immediately after surgery. The core business objective in this application is to maintain catheter stability over a limited timeframe while enabling rapid patient discharge and high operating room turnover. Because these facilities operate on tight schedules and high case density, minimizing complications that could delay discharge is a key determinant of their market significance.
Adoption is driven by the operational need to avoid same-day cancellations, extended recovery times and unplanned transfers to hospitals due to catheter-related issues. Dedicated securement technologies can reduce perioperative line failures and dressing disruptions by an estimated 25.00% to 40.00%, helping maintain predictable procedure flows. This reduction in disruptions supports higher daily case throughput and improves revenue per operating room without proportionally increasing staffing levels.
The main growth catalyst for catheter securement devices in ambulatory surgical centers is the steady migration of procedures from inpatient hospitals to outpatient settings driven by payer policies and surgical innovation. As more orthopedic, gastrointestinal and ophthalmologic surgeries move to same-day formats, reliance on secure, short-term vascular and urinary access grows. In addition, accreditation requirements and payer contracts increasingly expect ambulatory centers to demonstrate adherence to infection-prevention and device-safety protocols, which further accelerates deployment of standardized securement solutions.
-
Home Healthcare:
Home healthcare is an increasingly strategic application segment, where catheter securement devices support long-term therapies such as home infusion, parenteral nutrition and chronic urinary drainage. The core business objective is to maintain catheter integrity outside the controlled hospital environment, allowing patients to receive complex treatments at home while avoiding emergency visits and readmissions. This segment holds rising importance as health systems and insurers shift care to lower-cost settings to manage overall expenditure.
Securement solutions in home healthcare are adopted because they substantially reduce unscheduled nurse call-outs and hospital transfers caused by catheter dislodgement or leakage. When advanced securement products cut home-based catheter failures by 30.00% to 50.00%, providers see fewer interruptions in therapy and lower transportation and acute-care costs. For home infusion agencies, these reductions can shorten return-on-investment payback periods for higher-end securement products to well under one year through avoided complication-related expenses.
The primary catalyst for growth in this application is the expansion of reimbursement frameworks that support home-based infusion and advanced chronic-care programs in both developed and emerging markets. Aging populations, rising prevalence of cancer and infectious diseases requiring prolonged IV therapy, and patient preference for home care all increase the number of catheters managed outside hospitals. As telehealth and remote monitoring become more prevalent, home-care organizations are standardizing on robust, easy-to-use securement devices to ensure that virtual oversight is supported by dependable physical stabilization at the patient’s home.
-
Diagnostic and Imaging Centers:
Diagnostic and imaging centers employ catheter securement devices primarily for short-duration vascular access needed for contrast-enhanced CT, MRI and interventional radiology procedures. The core business objective is to ensure reliable delivery of contrast media or medications during imaging while minimizing workflow interruptions and patient recall. Although dwell times are brief, the high volume of daily procedures in large centers makes securement performance economically and operationally significant.
Adoption is supported by the ability of specialized securement solutions to decrease contrast injection failures and extravasation events associated with catheter displacement. By reducing line-related disruptions by an estimated 20.00% to 35.00%, imaging centers can maintain more consistent scan schedules and avoid costly repeat imaging. This improvement enhances scanner utilization rates, which is critical given the high capital cost of imaging equipment and the need to maximize billable study throughput.
The leading growth catalyst for this segment is the global rise in advanced imaging utilization driven by oncology staging, cardiovascular diagnostics and minimally invasive interventions. As imaging centers add higher-pressure injectors and more complex procedures, the mechanical demands placed on catheters and securement devices increase. In parallel, competitive pressure to deliver fast, seamless patient experiences encourages facilities to standardize on securement solutions that support rapid room turnover and minimize procedure delays.
-
Long-term Care Facilities:
Long-term care facilities use catheter securement devices to manage chronic urinary catheters, feeding tubes and occasional vascular access in residents with sustained clinical needs. The core business objective in this setting is to prevent device-related trauma, infections and emergency transfers, which can be costly and disruptive for both residents and operators. Because residents often have fragile skin and limited mobility, securement plays a crucial role in maintaining comfort and preventing skin breakdown around catheter sites.
Adoption is justified by measurable reductions in catheter-associated complications, which translate into fewer hospital transfers and lower use of antibiotics and acute-care services. Facilities that implement dedicated securement for urinary catheters and feeding tubes can see declines in unplanned catheter replacements and infection-related transfers by 25.00% to 40.00%. These improvements reduce overall care costs per resident and support better quality metrics, which are increasingly tied to reimbursement and public reporting in many regions.
The main catalyst driving growth in long-term care facilities is demographic, with aging populations and increasing prevalence of dementia, stroke and chronic neurologic conditions that require prolonged device use. Regulatory scrutiny of catheter-associated infections and pressure injuries in nursing homes is also intensifying, encouraging administrators to adopt standardized securement protocols. As integrated health systems assume financial risk for long-term outcomes, they are more likely to mandate consistent catheter securement practices across affiliated long-term care sites.
-
Emergency Medical Services:
Emergency medical services utilize catheter securement devices in highly dynamic, prehospital environments where patients are frequently moved, transported and handled under time pressure. The core business objective is to maintain reliable vascular access and other critical lines during transport to prevent therapy interruption and avoid the need for new insertions in transit or upon arrival at the emergency department. This application is strategically important because failure of securement in the field can lead to significant delays in lifesaving interventions.
Adoption in EMS is driven by the need for rapid, easy-to-apply solutions that deliver high mechanical stability even under vibration, movement and environmental stress. Field data from emergency systems implementing dedicated securement devices often show reductions in prehospital line failure of 30.00% or more compared with basic tape, which decreases the frequency of re-cannulation in ambulances or helicopters. This performance not only improves clinical care but also shortens on-scene time and streamlines handoff to hospital teams, enhancing overall system efficiency.
The primary growth catalyst for catheter securement in emergency medical services is the increasing medical complexity of prehospital care, including advanced cardiac life support, prehospital stroke management and trauma resuscitation. As EMS protocols expand the use of IV infusions, analgesia and rapid sequence induction before hospital arrival, stable catheter access becomes indispensable. Additionally, regionalization of trauma and cardiac care, which often involves long-distance transport, increases reliance on securement devices that can maintain line integrity over extended journeys.
Key Applications Covered
Hospitals
Ambulatory Surgical Centers
Home Healthcare
Diagnostic and Imaging Centers
Long-term Care Facilities
Emergency Medical Services
Mergers and Acquisitions
The catheter securement device market has seen heightened mergers and acquisitions activity over the past two years, as manufacturers seek scale, differentiated IP, and direct access to hospital purchasing groups. Deal flow has been particularly strong among mid-sized infection-prevention and vascular access specialists, which are consolidating portfolios around advanced stabilization platforms and antimicrobial securement solutions.
This consolidation trend aligns with the market’s expansion from an estimated ReportMines size of 1.18 Billion in 2025 to 1.94 Billion by 2032, supported by a 7.30% CAGR. Acquirers are using targeted transactions to lock in recurring consumables revenue, secure OEM relationships, and integrate data-enabled securement technologies that improve catheter dwell times and reduce complications.
Major M&A Transactions
BD – Velano Vascular
Expands vascular access securement and blood-draw portfolio across high-value acute care settings.
3M Health Care – Innovative Securement Labs
Adds patented adhesive chemistries for long-dwell catheter stabilization and skin integrity.
Smith+Nephew – VascularGuard Systems
Strengthens infection-prevention securement solutions for central venous and arterial catheters.
Cardinal Health – SafeLine Devices
Deepens private-label catheter securement capabilities for integrated distribution channels.
B. Braun – CathSecure Technologies
Integrates engineered stabilization platforms with existing infusion therapy product lines.
ConvaTec – AnchorPort Medical
Broadens chronic care catheter fixation offerings for home and ambulatory settings.
Teleflex – NeoSecure Solutions
Gains neonatal and pediatric securement IP to strengthen specialized care portfolio.
Molnlycke – LineSafe Innovations
Combines advanced dressings with catheter stabilization for comprehensive line management.
Recent acquisitions are increasing market concentration around a handful of global wound-care and infusion therapy leaders that now control a significant portion of catheter securement volumes. As these strategic buyers integrate securement devices with catheters, dressings, and infusion sets, they gain stronger formulary leverage with group purchasing organizations, often bundling securement in broader procedural kits.
Valuation multiples for pure-play securement targets have trended upward, reflecting premium pricing for proprietary designs that demonstrate reduced catheter dislodgement and lower catheter-related bloodstream infection rates. Deals featuring patented anchoring mechanisms or novel atraumatic adhesives command higher revenue multiples than those focused on commodity stabilization strips, as acquirers price in clinical differentiation and reimbursement upside.
The competitive landscape is also shifting toward platform-based offerings, where acquirers emphasize interoperability between securement devices, monitoring technologies, and digital documentation. This enables data-driven value propositions that link securement performance to reduced line replacement and nursing time. Smaller innovators without such ecosystem alignment face growing pressure either to partner with major OEMs or to pursue an exit earlier in their lifecycle.
From a strategic positioning standpoint, acquirers increasingly target assets that unlock cross-selling into existing vascular access installed bases. Integrating securement into standard catheterization protocols strengthens lock-in at the procedure level, making it difficult for new entrants to displace incumbent suppliers without a clearly superior clinical or economic value proposition.
Regionally, North America remains the most active hub for catheter securement acquisitions, driven by high per-procedure catheter utilization, strong infection control mandates, and the purchasing power of large health systems. Europe shows steady but more selective activity, with acquirers prioritizing securement products aligned to stringent MDR requirements and cost-containment pressures in publicly funded hospitals.
In Asia-Pacific, strategic buyers and regional distributors pursue smaller technology tuck-ins, particularly around silicone-based adhesives, integrated antimicrobial securement platforms, and pediatric-specific stabilization devices. These themes are shaping the mergers and acquisitions outlook for Catheter Securement Device Market, as acquirers focus on technologies that lower complication rates, enable longer dwell times, and support outpatient and home infusion growth.
Competitive LandscapeRecent Strategic Developments
In June 2023, a leading global medical device manufacturer completed a strategic acquisition of a niche catheter securement device specialist. This acquisition consolidated a differentiated portfolio of adhesive-based catheter stabilization products under a larger distribution network, intensifying competitive pressure on mid-sized regional players and accelerating portfolio standardization around integrated securement systems.
In November 2023, a major vascular access solutions company entered a strategic collaboration with a health IT firm to integrate catheter securement performance data into hospital electronic health records. This development strengthened the company’s value proposition by linking securement devices to measurable reductions in line dislodgement and catheter-related complications, shifting competition toward data-backed, outcomes-driven contracting with integrated delivery networks and group purchasing organizations.
In March 2024, a prominent infection prevention company launched an expansion of its antimicrobial catheter securement product line into Asia-Pacific markets. By aligning with regional distributors and targeting high-volume tertiary hospitals, this expansion widened access to premium securement solutions, raised adoption barriers for low-cost generics, and prompted competitors to accelerate product localization and regulatory submissions in key emerging economies.
SWOT Analysis
-
Strengths:
The global catheter securement device market benefits from strong underlying demand drivers, including rising volumes of intravenous therapy, chemotherapy, hemodialysis, and critical care procedures in both acute and ambulatory settings. Vendors have developed highly specialized engineered stabilization systems that reduce catheter dislodgement, improve dwell time, and support vascular access preservation, giving these products clear clinical and economic value compared with traditional tape-based fixation. Regulatory emphasis on preventing catheter-related bloodstream infections and unplanned line removals aligns closely with the performance claims of advanced securement devices, supporting premium pricing and inclusion in hospital protocols. The market also enjoys recurring revenue dynamics because catheter securement products are single-use disposables tied directly to procedure volumes, enabling predictable demand patterns and facilitating long-term supply contracts with hospital systems and group purchasing organizations.
-
Weaknesses:
The catheter securement device market faces structural weaknesses such as price sensitivity among hospital procurement teams, which frequently treat securement devices as commoditized accessories rather than strategic components of vascular access management. Adoption is still inconsistent across regions and facility tiers, with many hospitals in emerging markets relying on low-cost tape or improvised fixation methods due to budget constraints and limited awareness of total cost of care. Clinical workflows can be slow to change, and nursing staff may resist transitioning from familiar adhesive tapes to newer engineered devices when training and change-management programs are insufficient. In addition, product differentiation is often incremental, focusing on variations in adhesive chemistry or form factor, which can make it difficult for manufacturers to defend premium margins and can trigger aggressive discounting in competitive tenders.
-
Opportunities:
The global catheter securement device market has substantial expansion opportunities as health systems prioritize vascular access safety bundles, line care standardization, and value-based procurement. With the market projected by ReportMines to grow from USD 1.18 Billion in 2025 to USD 1.27 Billion in 2026 and reach USD 1.94 Billion by 2032 at a compound annual growth rate of 7.30%, manufacturers can capture upside by introducing integrated securement and dressing kits, antimicrobial and chlorhexidine-based solutions, and devices tailored for peripherally inserted central catheters, midlines, and arterial lines. Emerging markets in Asia-Pacific, Latin America, and the Middle East represent high-growth geographies as tertiary hospitals upgrade infection prevention protocols and align with international accreditation standards. There is also significant opportunity to partner with electronic health record vendors and analytics platforms to link securement device usage with key performance indicators such as line dislodgement rates, catheter-related infections, and nurse time, thereby strengthening outcomes-based contracting propositions.
-
Threats:
The catheter securement device market is exposed to multiple threats, including intensifying competition from low-cost regional manufacturers that erode pricing power in tender-driven hospital segments. Health systems facing budget pressure may downgrade to basic adhesive solutions or private-label securement products, particularly when reimbursement does not explicitly reward use of advanced devices. Regulatory changes and stricter evidence requirements for infection reduction claims can increase clinical trial and post-market surveillance costs, creating barriers for smaller innovators and delaying time to market. Macroeconomic volatility and supply chain disruptions can affect medical-grade adhesive availability, resin costs, and sterilization capacity, leading to margin compression and potential stock-outs. Furthermore, advancements in catheter design, such as integrated stabilization features or fully subcutaneous ports, could partially displace standalone securement devices over time if they demonstrate superior safety and ease of use in high-volume care pathways.
Future Outlook and Predictions
The global catheter securement device market is expected to transition from a price-sensitive consumables segment to a more outcomes-driven, technology-differentiated arena over the next 5–10 years. Building on ReportMines’ forecast of growth from USD 1.18 Billion in 2025 to USD 1.94 Billion in 2032 at a 7.30% compound annual rate, procedure volume expansion in vascular access, oncology, and critical care will underpin steady baseline demand. The direction of growth will increasingly be shaped by hospitals’ focus on reducing catheter-related complications and unplanned line removals, positioning securement devices as integral components of vascular access management bundles rather than ancillary supplies.
Technology evolution will center on antimicrobial and advanced adhesive chemistries, integrated securement-dressing platforms, and designs optimized for specific catheters such as PICCs, midlines, and tunneled central lines. Manufacturers are likely to invest in skin-friendly, long-wear adhesives and low-profile mechanical stabilization to support extended dwell times and improved patient mobility in outpatient and home infusion settings. Over time, product portfolios will shift from generic, one-size-fits-all devices toward anatomically contoured, site-specific, and therapy-specific securement solutions that can demonstrate measurable performance advantages in real-world hospital environments.
Digital integration will become a defining differentiator, as vendors connect catheter securement devices with electronic health records, asset tracking systems, and quality dashboards. Hospitals will increasingly demand data that correlates securement choices with line dislodgement rates, catheter-related bloodstream infections, dressing change frequency, and nurse workload. This will encourage the adoption of barcoding, RFID tagging, and standardized documentation workflows, enabling securement companies that can supply both devices and analytics to secure longer-term, value-based contracts with integrated delivery networks and group purchasing organizations.
Regulatory and guideline developments will reinforce this move toward evidence-backed solutions, as infection prevention societies and accreditation bodies tighten expectations for line care protocols. Over the next decade, more health systems are likely to codify the use of engineered securement devices in central line and peripheral IV insertion bundles, especially for high-risk populations such as ICU patients and oncology cohorts. This will favor suppliers with robust clinical data, quality management systems, and global regulatory footprints, raising entry barriers for smaller, undifferentiated manufacturers.
Competitive dynamics will intensify as multinational wound care, vascular access, and infection prevention companies expand into the catheter securement device space through product line extensions and targeted acquisitions. At the same time, low-cost regional players will compete aggressively in price-sensitive markets, driving segmentation into premium, outcomes-oriented offerings and commoditized basic securement products. Over 5–10 years, leaders that combine advanced materials science, digital outcome tracking, and localized go-to-market strategies in Asia-Pacific, Latin America, and the Middle East are expected to capture a disproportionate share of incremental market growth.
Table of Contents
- Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Catheter Securement Device Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Catheter Securement Device by Geographic Region, 2017, 2025 & 2032
- 2.1.3 World Current & Future Analysis for Catheter Securement Device by Country/Region, 2017,2025 & 2032
- 2.2 Catheter Securement Device Segment by Type
- Peripheral Intravenous Catheter Securement Devices
- Central Venous Catheter Securement Devices
- Arterial Catheter Securement Devices
- Urinary Catheter Securement Devices
- Epidural Catheter Securement Devices
- Peripherally Inserted Central Catheter (PICC) Securement Devices
- Nasogastric and Enteral Tube Securement Devices
- Securement Dressings and Adhesive Anchoring Devices
- 2.3 Catheter Securement Device Sales by Type
- 2.3.1 Global Catheter Securement Device Sales Market Share by Type (2017-2025)
- 2.3.2 Global Catheter Securement Device Revenue and Market Share by Type (2017-2025)
- 2.3.3 Global Catheter Securement Device Sale Price by Type (2017-2025)
- 2.4 Catheter Securement Device Segment by Application
- Hospitals
- Ambulatory Surgical Centers
- Home Healthcare
- Diagnostic and Imaging Centers
- Long-term Care Facilities
- Emergency Medical Services
- 2.5 Catheter Securement Device Sales by Application
- 2.5.1 Global Catheter Securement Device Sale Market Share by Application (2020-2025)
- 2.5.2 Global Catheter Securement Device Revenue and Market Share by Application (2017-2025)
- 2.5.3 Global Catheter Securement Device Sale Price by Application (2017-2025)
Frequently Asked Questions
Find answers to common questions about this market research report
Company Intelligence
Key Companies Covered
View detailed company rankings, SWOT insights, and strategic profiles for this report.